Načítá se...
O4.08 AGI5198, AN INHIBITOR OF IDH1R132H, PROTECTS IDH1R132H HCT116 CELLS AGAINST IRRADIATION
BACKGROUND: IDH1(R132H) mutations are both inaugural events in the formation of glioma and associated with prolonged glioma patient survival. The IDH1(R132H) mutation confers a neo-enzymatic function that results in accumulation of the oncometabolite D-2-hydroxyglutarate (D-2HG), which promotes glio...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2014
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185649/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.29 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|